| # | Drug | Count |
|---|---|---|
| 0 | DOXORUBICIN | 19 |
| 1 | CYCLOPHOSPHAMIDE | 17 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 17 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 17 |
| 4 | BRENTUXIMAB VEDOTIN | 15 |
| 5 | PREDNISONE | 10 |
| 6 | PREDNISOLONE | 9 |
| 7 | PREDNISOLONE ORAL | 9 |
| 8 | PREDNISOLONE ORAL SOLUTION | 9 |
| 9 | DOXORUBICIN HYDROCHLORIDE | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PRALATREXATE | 1 | 0.0015 |
| 1 | BRENTUXIMAB VEDOTIN | 15 | 0.0014 |
| 2 | HYDROCORTISONE SODIUM SUCCINATE | 3 | 0.0008 |
| 3 | ROMIDEPSIN | 1 | 0.0006 |
| 4 | BRIGATINIB | 1 | 0.0003 |
| 5 | FOSCARNET SODIUM | 1 | 0.0002 |
| 6 | CRIZOTINIB | 3 | 0.0002 |
| 7 | DOXORUBICIN HYDROCHLORIDE | 7 | 0.0002 |
| 8 | DOXORUBICIN | 19 | 0.0002 |
| 9 | IFOSFAMIDE FOR INJECTION | 3 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD30-directed Immunoconjugate [EPC] | 15 | 0.0014 |
| 1 | Topoisomerase Inhibitor [EPC] | 7 | 0.0001 |
| 2 | Alkylating Drug [EPC] | 20 | 0.0001 |
| 3 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 6 | 0.0000 |
| 6 | Corticosteroid [EPC] | 19 | 0.0000 |
| 7 | Nucleoside Analog Antiviral [EPC] | 1 | 0.0000 |
| 8 | Kinase Inhibitor [EPC] | 6 | 0.0000 |
| 9 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 1 | 0.0000 |